Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 781–840 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
… care, supporting its use in both clinical practice and trials. ScleroID captures the multidimensional burden of SSc regardless of disea…
…and patient-directed digital outreach can significantly improve Cologuard usage, ultimately leading to an increase in CRC screening compl…
…ignificant.Conclusion Participants with EoP are exposed to more nicotine and tobacco-related toxicants than those without EoP, likely la…
…A, anti Ro52 and low titer of IgM-RF) is initially treated with hydroxychloroquine, azathioprine and topical steroids. Because of insufficient imp…
…le for propensity-score matching (1:3 cannabis user: non-user). Cannabis use status was determined via natural language processing of cl…
…pecialist for monitoring/initiation of antiviral therapy before Rituximab treatment.The role of pharmacy technicians contributing to pati…
…ammation, fibrosis, and destruction of intrahepatic bile ducts. Elafibranor, a peroxisome proliferator-activated receptor (PPAR) agonist ex…
…py, while 27% were prescribed second-line treatments, including Bezafibrate (31 patients), Obeticholic acid (20 patients), and Elafibranor …
…ra-orthodox Jews and 35% general public; ps <0.001).Conclusions IQOS was framed more positively in media targeting minority populati…
…titution rate (β=4.26 (95% CI 1.03 to 7.50) p=0.01).Conclusions IQOS fully substituted for cigarettes in ~20% of people who were not…
…dosing in patients undergoing pancreatectomy to 98.0%. Although pip–tazo reduced SSI rates, the addition of a ringed wound protector in …
…us reports that UDCA acts as a gut FXR antagonist. In addition, UDCA seems to be exerting liver protective effects predominantly in …